ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,370.33
0.00%
Dow Jones
39,671.04
-0.51%
Gold vs US Dollar
2,363.655
-0.77%
Brent Oil
81.425
-0.13%
Bitcoin
69,362.68
0.38%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Clearside Biomedical Inc (CLSD)

  7. Clearside Biomedical Inc (CLSD) News

Clearside Biomedical (CLSD)

Clearside Biomedical Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CLSD
DateTimeSourceHeadlineSymbolCompany
21/05/202412:05GlobeNewswire Inc.Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space (SCS®) Injection in Leading Peer-Reviewed Industry Journal, RETINA®NASDAQ:CLSDClearside Biomedical Inc
10/05/202421:31Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CLSDClearside Biomedical Inc
09/05/202421:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLSDClearside Biomedical Inc
09/05/202421:05GlobeNewswire Inc.Clearside Biomedical Announces First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:CLSDClearside Biomedical Inc
08/05/202421:15GlobeNewswire Inc.Clearside Biomedical to Participate in Fireside Chat at the Citizens JMP Life Sciences ConferenceNASDAQ:CLSDClearside Biomedical Inc
30/04/202412:05GlobeNewswire Inc.Clearside Biomedical to Report First Quarter 2024 Financial Results and Provide Corporate Update on Thursday, May 9, 2024NASDAQ:CLSDClearside Biomedical Inc
16/04/202412:05GlobeNewswire Inc.Clearside Biomedical Appoints Seasoned Biotechnology Executive Anthony S. Gibney to its Board of DirectorsNASDAQ:CLSDClearside Biomedical Inc
02/04/202412:05GlobeNewswire Inc.Clearside Biomedical to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:CLSDClearside Biomedical Inc
18/03/202411:05GlobeNewswire Inc.Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical OfficerNASDAQ:CLSDClearside Biomedical Inc
12/03/202420:05GlobeNewswire Inc.Clearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:CLSDClearside Biomedical Inc
29/02/202412:05GlobeNewswire Inc.Clearside Biomedical to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on Tuesday, March 12, 2024NASDAQ:CLSDClearside Biomedical Inc
08/02/202422:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLSDClearside Biomedical Inc
08/02/202421:52Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CLSDClearside Biomedical Inc
07/02/202413:00GlobeNewswire Inc.Clearside Biomedical Announces Pricing of $15 Million Registered Direct OfferingNASDAQ:CLSDClearside Biomedical Inc
01/02/202421:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLSDClearside Biomedical Inc
19/01/202423:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CLSDClearside Biomedical Inc
19/01/202420:04Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CLSDClearside Biomedical Inc
28/12/202321:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLSDClearside Biomedical Inc
14/12/202312:05GlobeNewswire Inc.Clearside Biomedical Reports Significant Progress in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMDNASDAQ:CLSDClearside Biomedical Inc
13/11/202321:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CLSDClearside Biomedical Inc
13/11/202321:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLSDClearside Biomedical Inc
13/11/202321:05GlobeNewswire Inc.Clearside Biomedical Announces Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:CLSDClearside Biomedical Inc
08/11/202312:05GlobeNewswire Inc.Clearside Biomedical to Participate in Fireside Chat at the Stifel 2023 Healthcare ConferenceNASDAQ:CLSDClearside Biomedical Inc
07/11/202321:20GlobeNewswire Inc.Clearside Biomedical’s Versatile Suprachoroidal Injection Platform Highlighted in Four Ophthalmic Indications in Clinical Data Presentations at AAO 2023 Annual MeetingNASDAQ:CLSDClearside Biomedical Inc
03/11/202316:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CLSDClearside Biomedical Inc
03/11/202316:00GlobeNewswire Inc.BioCryst and Clearside Biomedical Enter Partnership to Develop Avoralstat for Diabetic Macular Edema Using Clearside’s Proprietary SCS Microinjector®NASDAQ:CLSDClearside Biomedical Inc
02/11/202311:05GlobeNewswire Inc.Clearside Biomedical Announces Presentations at the American Academy of Ophthalmology 2023 Annual MeetingNASDAQ:CLSDClearside Biomedical Inc
01/11/202311:05GlobeNewswire Inc.Clearside Biomedical Completes Recruitment in ODYSSEY Phase 2b Clinical Trial of CLS-AX in Wet AMDNASDAQ:CLSDClearside Biomedical Inc
31/10/202311:05GlobeNewswire Inc.Clearside Biomedical to Report Third Quarter 2023 Financial Results and Provide Corporate Update on Monday, November 13, 2023NASDAQ:CLSDClearside Biomedical Inc
16/10/202312:05GlobeNewswire Inc.Clearside Biomedical Positive OASIS and Extension Study Data Presented at The Retina Society 56th Annual Scientific MeetingNASDAQ:CLSDClearside Biomedical Inc
 Showing the most relevant articles for your search:NASDAQ:CLSD

Your Recent History

LSE
ITM
Itm Power
LSE
POS
Plexus
LSE
AMRQ
Amaroq Minerals
LSE
CNR
Condor Gold
LSE
AV.
Aviva
LSE
GKP
Gulf Keystone Petroleum
LSE
LONG
Longships
LSE
APTA
Aptamer
LSE
AET
Afentra
LSE
RR.
Rolls-royce
LSE
MNL
Manchester & London Inve...
LSE
VLG
Venture Life
LSE
PXC
Phoenix Copper
LSE
SYME
Supply@me Capital
LSE
AAZ
Anglo Asian Mining
LSE
VAL
Valirx
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved